The safer use of medicines depends on everyone’s constant awareness and vigilance – strong communications practice is an important part of that process.
Solid communications strategies in an area as complex as pharmacovigilance are crucial. A reliable flow of relevant information allows people to stay informed about the benefits and risks of medicines, the importance of reporting adverse drug reactions (ADRs), and the role of dialogues between patients and physicians.
Uppsala Monitoring Centre strives to meet a global need for better communication practices in our field. Our communication activities focus on raising awareness of UMC’s work, the importance of pharmacovigilance, and the basics of how adverse drug reactions occur and should be handled.
We have also taken on the mission to strengthen communications capacities within the global pharmacovigilance community. We do this through training and lectures, social science-based research, and by producing and sharing innovative campaign materials and information packages – much of which you can find on this page.
Tune in to our podcast to hear about the most pressing issues in medicines safety today. Every month we are joined in the studio by a special guest.
UMC has produced a range of materials and campaigns that are aimed directly at the general public and patient populations. We encourage pharmacovigilance actors to use these to spread much-needed information in their own communities.
During the annual #MedSafetyWeek in autumn, UMC teams up with medicine regulatory authorities around the world, to launch a social media campaign that raises awareness of side effects of medicines.
WHO organises World Antibiotic Awareness Week in November each year, to bring attention to the spread of antibiotic resistance. UMC makes a small campaign kit available for free to the public, based on our comic book Annie & Mac’s Adventures.